post-add

Articles for Regulatory

BMC Informed Bombay High Court, It Does Not Expect COVID's Third Wave

Senior advocate Anil Sakhare, who appeared for BMC, informed a bench of Chief Justice Dipankar Datta and Justice Girish Kulkarni that over 82 lakh persons had received the first dose of the COVID vaccination and over 42 lakh had received the second dosage.

Read More
Under AB PM-JAY Scheme, NHA Is Revising Health Benefit Packages

These improvements will enable the scheme's effective implementation and will be made in the Transaction Management System to ensure portability is not hampered.

Read More
Cadila Gets DCGI Nod For Two-dose COVID Vaccine Phase III Trials

The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on 20th August.

Read More
Russia Sees No Hurdles For WHO Approval Of Sputnik V Vaccine

The Sputnik V shot, widely used in Russia and approved for use in over 70 countries, is undergoing a review by the WHO and the European Medicines Agency (EMA). Their approval could open up new markets for the shot, especially in Europe.

Read More
Countries Need Not Wait For Widespread COVID Vaccination Before Reopening Schools: World Bank

In a new policy note, the World Bank's Education team has noted that the experiences from countries around the world where schools have reopened suggest that with adequate mitigation strategies, schools pose low risks for disease transmission among students, staff and communities.

Read More
Zydus Cadila Proposes Rs 1900 For Three Dose COVID Vaccine; Government Negotiating To Bring It Down

The government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-Coronavirus vaccination drive shortly.

Read More
Only Five Deaths Due To COVID Recorded In September In Delhi: Data

Daily case count had dropped to 17 on September 13, with no death being recorded, while the positivity rate stood at 0.04 per cent, according to official figures.

Read More
EU Finds J&J COVID Shot Possibly Linked To Another Rare Clotting Condition

The European Medicines Agency also recommended immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as an adverse reaction with an unknown frequency to the J&J vaccine product information and to AstraZeneca's vaccine.

Read More

Subscribe to our newsletter to get updates on our latest news